Equivalence Trials as Topic
"Equivalence Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about trials that aim to show a new treatment is no better and no worse than the standard treatment.
Descriptor ID |
D000074099
|
MeSH Number(s) |
E05.318.760.250.500.365.500.125 N05.715.360.775.088.500.387.500.250 N06.850.520.450.250.250.365.500.250
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Equivalence Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Equivalence Trials as Topic".
This graph shows the total number of publications written about "Equivalence Trials as Topic" by people in this website by year, and whether "Equivalence Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 0 | 1 | 1 |
2020 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Equivalence Trials as Topic" by people in Profiles.
-
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15?years. Contemp Clin Trials. 2024 Jul; 142:107540.
-
Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clin Pharmacol Ther. 2021 04; 109(4):1034-1044.
-
Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial. J Acquir Immune Defic Syndr. 2019 02 01; 80(2):224-233.